Entadfi Interactions
There are 342 drugs known to interact with Entadfi (finasteride/tadalafil), along with 12 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 33 are major, 209 are moderate, and 100 are minor.
- View all 342 medications that may interact with Entadfi
- View Entadfi alcohol/food interactions (1)
- View Entadfi disease interactions (12)
Most frequently checked interactions
View interaction reports for Entadfi (finasteride / tadalafil) and the medicines listed below.
- Adcirca (tadalafil)
- Adderall (amphetamine / dextroamphetamine)
- albuterol
- alfuzosin
- allopurinol
- amoxicillin / clavulanate
- anastrozole
- Anoro Ellipta (umeclidinium / vilanterol)
- apple cider vinegar
- Asacol (mesalamine)
- ashwaganda
- aspirin
- Astepro Allergy (azelastine nasal)
- Augmentin (amoxicillin / clavulanate)
- azelastine nasal
- baclofen
- beetroot
- Benadryl (diphenhydramine)
- beta sitosterol
- betamethasone
- Bevespi Aerosphere (formoterol / glycopyrrolate)
- boron
- Breo Ellipta (fluticasone / vilanterol)
- Breyna (budesonide / formoterol)
- Breztri Aerosphere (budesonide / formoterol / glycopyrrolate)
- Brovana (arformoterol)
- buchu
- calcium citrate
- carvedilol
- duloxetine
Entadfi alcohol/food interactions
There is 1 alcohol/food interaction with Entadfi (finasteride / tadalafil).
Entadfi disease interactions
There are 12 disease interactions with Entadfi (finasteride / tadalafil) which include:
- cardiovascular disease
- renal dysfunction
- pulmonary disease
- liver disease
- urinary obstruction
- priapism
- alcoholism
- hearing loss
- liver disease
- retinitis pigmentosa
- seizure disorders
- Tadalafil-visual disorders
More about Entadfi (finasteride / tadalafil)
- Entadfi consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous genitourinary tract agents
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.